For cell and gene therapies, all stages of the drug development life cycle are complex. The patient, product and supply chain requires specialized sets of capabilities, as standards and protocols differ from more traditional therapy areas.
Suite 11a, Cedar Court
Grove Park
White Waltham
Maidenhead
SL6 3LW
info@icr-global.org